Evidence map›Paper›PMID 32168746›Full record

ReviewMolecules (Basel, Switzerland)2020

José E S Nunes, Mario A Duque, Talita F de Freitas, Luiza Galina, Luis F S M Timmers, Cristiano V Bizarro, Pablo Machado, Luiz A Basso, Rodrigo G Ducati

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Menaquinone depletion resensitises bedaquiline-resistant tuberculosis.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Mutations in the circadian cycle drive adaptive plasticity in cyanobacteria.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Identification of novel drug targets forFrontiers in bioinformatics · 2024
    Article
  14. MedComm · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Functional Analysis of Hypothetical Proteins ofBioinformatics and biology insights · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

José E S NunesCentro de Pesquisas em Biologia Molecular e Funcional (CPBMF) and Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS 90619-900, Brazil.
Mario A DuqueCentro de Pesquisas em Biologia Molecular e Funcional (CPBMF) and Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS 90619-900, Brazil.
Talita F de FreitasCentro de Pesquisas em Biologia Molecular e Funcional (CPBMF) and Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS 90619-900, Brazil.ORCID 0000-0002-7497-3337
Luiza GalinaCentro de Pesquisas em Biologia Molecular e Funcional (CPBMF) and Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS 90619-900, Brazil.ORCID 0000-0003-4394-221X
Luis F S M TimmersPrograma de Pós-Graduação em Biotecnologia (PPGBiotec), Universidade do Vale do Taquari (Univates), Lajeado, RS 95914-014, Brazil.
Cristiano V BizarroCentro de Pesquisas em Biologia Molecular e Funcional (CPBMF) and Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS 90619-900, Brazil.ORCID 0000-0002-2609-8996
Pablo MachadoCentro de Pesquisas em Biologia Molecular e Funcional (CPBMF) and Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS 90619-900, Brazil.
Luiz A BassoCentro de Pesquisas em Biologia Molecular e Funcional (CPBMF) and Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS 90619-900, Brazil.
Rodrigo G DucatiCentro de Pesquisas em Biologia Molecular e Funcional (CPBMF) and Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS 90619-900, Brazil.ORCID 0000-0002-8783-8847
Pontifícia Universidade Católica do Rio Grande do Sul · BRUnivates · BR

Funding

CNPq 305203/2018-5CNPq 310344/2016-6CNPq 407537/2018-0CNPq 520182/99-5Universidade do Vale do Taquari - Univates 10901360
6 · The paper itself

Abstract

Roughly a third of the world's population is estimated to have latent

Indexed as

Gene Expression Regulation, BacterialAntitubercular AgentsBacterial ProteinsDrug DesignEnzyme InhibitorsHumansLatent TuberculosisMetabolic Networks and PathwaysMycobacterium tuberculosisShikimic AcidStructure-Activity RelationshipTuberculosis, PulmonaryAntitubercular AgentsBacterial ProteinsEnzyme InhibitorsShikimic Acidenzyme drug targetenzyme inhibitionhuman tuberculosisMycobacterium tuberculosisrational drug designshikimate pathway

Identifiers

PMID32168746
PMCPMC7144000
OpenAlexW3011400347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.